August 23, 2017
Yesterday, the IBB +1.92%, the XBI +2.39%, The XLV +1.21% and the IWM +1.08% were up as the VIX was down -13.95% and sector volume was below even normal
… With a “happy” high, a low usually follows
Preview RMi's morning call. To get the pre-open briefing, plus daily access to the happenings and realities of “our” universe - SUBSCRIBE!
Pre-open indications: 3 BUYs and 2 SELLs
June 1, 2017
Calling out the recent 10-Q page 17’s paragraph re a 24 page legal filing - this is what BSTG did NOT want investors to know or read!
August 22, 2017
A response to speculation and oversold conditions
While sentiment is overlooked and volume is still very low
As I had stated this a.m., “buy the oversold at a bottom and bid’em up to exit as many become overbought.”
Pre-open indications: 3 hits and 1 miss
Out and about: Biostage (BSTG) makes yet another low of -5.27% or -0.0148 to $0.26 after being down -10.44% to $0.25, a far cry from Q1/17’s start at $0.87, Q1/16’s $2.60, Q1/15’s $4.43 … a “walking dead” company who can’t even get an IND filed as their proof of concept was found “unable to be filed” having burned through $30 M and whose current +$3 M funding is all about salary continuation with a new development “tunnel ”! And I was initially their biggest supporter …
It’s called premium content for a reason … I define insight from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!
Others don’t even come close!
I answer one question, in which company should investors commit and keep their money.
June 27, 2017
On track for top-line 1 year powered data and potential BLA filing in Q3/18 BLA to the FDA shortly thereafter and, if approved, launching NeoCart in the second half of 2019
June 26, 2017
BLUE closed down -$4.20 to $1.06.90 after Monday's -$0.90 or -0.80% to $111.10
June 20, 2017
SGMO closes UP +$0.25 to $8.20 and promptly dives -$0.70 or -8.54% to $7.50 SGMO prices 10 M shares at $7.25
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.
8 hours 8 min ago
RegMed Investors’ (RMi) pre-open indications, watch your corners